Eight chronic schizophrenic inpatients received adjunctive fluoxetine (20 mg/day) for a mean of 10.6 weeks in an open clinical trial. Clinical state improved in all patients. Violent incidents decreased, while participation in programs and socialization increased.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of Neuropsychiatry and Clinical Neurosciences|
|State||Published - Jan 1 1990|
ASJC Scopus subject areas
- Clinical Neurology
- Psychiatry and Mental health